SeouLin Bioscience Co. Ltd. | Income Statement
Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
Sales/Revenue
42,196
37,662
41,628
44,889
42,619
Cost of Goods Sold (COGS) incl. D&A
30,951
25,723
30,697
32,807
30,595
Gross Income
11,245
11,939
10,932
12,082
12,024
SG&A Expense
9,168
8,938
8,865
9,619
10,573
EBIT
4,275
2,699
1,757
2,174
1,148
Unusual Expense
-
-
-
480
443
Non Operating Income/Expense
325
117
105
2,789
545
Interest Expense
266
303
277
35
84
Pretax Income
5,078
3,121
2,200
5,127
2,824
Income Tax
921
435
427
970
556
Equity in Affiliates
4
4
13
1
-
Consolidated Net Income
4,160
2,682
1,761
4,158
2,268
Net Income
4,160
2,668
1,825
4,073
2,061
Net Income After Extraordinaries
4,160
2,668
1,825
4,073
2,061
Net Income Available to Common
4,160
2,668
1,825
4,073
2,061
EPS (Basic)
643.99
412.94
277.91
612.01
305.00
Basic Shares Outstanding
6
6
7
7
7
EPS (Diluted)
644.09
413.02
269.27
594.58
299.97
Diluted Shares Outstanding
6
6
7
7
7
EBITDA
4,921
3,524
2,581
2,953
2,222
Other Operating Expense
2,198
302
309
289
303
Non-Operating Interest Income
561
602
436
254
180
Minority Interest Expense
-
14
64
85
207
Equity in Affiliates (Pretax)
-
-
-
-
28
About SeouLin Bioscience Co.
View Profile
